0960B |
Cannabinoids Panel, Blood |
0960FL |
Cannabinoids Panel, Fluid |
0960SP |
Cannabinoids Panel, Serum/Plasma |
0960TI |
Cannabinoids Panel, Tissue |
0964U |
Cannabinoid Metabolite, Urine |
0966B |
Cannabis Plus Recent Use Markers, Blood |
0966SP |
Cannabis Plus Recent Use Markers, Serum/Plasma |
1876FL |
Drug Screen - Expanded, Fluid |
8052FL |
Postmortem, Expanded, Fluid (Forensic) |
8052TI |
Postmortem, Expanded, Tissue (Forensic) |
8062FL |
Postmortem, Expanded w/o Alcohol, Fluid (Forensic) |
8062TI |
Postmortem, Expanded w/o Alcohol, Tissue (Forensic) |
8092TI |
Postmortem, Prescription Drugs Screen, Tissue (Forensic) |
8104B |
Postmortem, Fire Death Screen, Blood (Forensic) |
8892OF |
Delta-9 THC (Qualitative), Oral Fluid (Saliva) |
8897OF |
Drugs of Abuse (7 Panel) (Qualitative), Oral Fluid (Saliva) |
8898OF |
Drugs of Abuse (6 Panel) (Qualitative), Oral Fluid (Saliva) |
8900OF |
Delta-9 THC (Quantitative), Oral Fluid (Saliva) |
9145UC |
Comprehensive Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |